Loading clinical trials...
Loading clinical trials...
A Single-Center, Single-Dose, Double-Blind, Modified-Double-Dummy, Placebo and Active-Controlled, Randomized, Three-Way, Six-Sequence Cross-Over Study to Investigate the Effect of JNJ-39758979 on Histamine Induced Pruritus in Healthy Male Subjects
Conditions
Interventions
A:JNJ-39758979/Placebo #1
C:Cetirizine/JNJ-39758979 Matching Placebo
+1 more
Locations
1
United Kingdom
Harrow, United Kingdom
Start Date
February 1, 2010
Completion Date
May 1, 2010
Last Updated
September 4, 2013
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions